mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
0.0004 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0004 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |